Temporal trends in hepatitis C-related hospitalizations, United States, 2000-2019.
Megan G HofmeisterYuna ZhongAnne C MoormanChristina R SamuelEyasu H TeshalePhilip R SpradlingPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Although multiple factors likely contributed, overall HCV-related hospitalization rates declined steadily after 2013, coinciding with the release of DAAs. However, the declines were not observed equally among age, race/ethnicity, or insurance categories. Expanded access to DAA treatment is needed, particularly among Medicaid and Medicare recipients, to reduce disparities and morbidity, and eliminate hepatitis C as a public health threat.